Developing models to understand infectious diseases.
Official title: Pre-Clinical Models of Infectious Diseases
Funded at Johns Hopkins University · NIH-11197687 · Data updated 2026-11-12
This study is working on new ways to understand and treat infectious diseases, so that patients can benefit from better medicines and vaccines in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | July 15, 2024 |
| Project end | July 14, 2031 |
| Funding year | 2024 |
| Award (this year) | $2,500 |
| NIH project number | 75N93024D00014-0-759302400001-1 |
| Project ID | NIH-11197687 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research would include individuals at risk of infectious diseases or those who have been diagnosed with such conditions.
✕Less likely to help
Patients with non-infectious diseases or those who are not at risk for infectious diseases may not receive any benefit from this research.
What this research studies
This research focuses on creating pre-clinical models to better understand infectious diseases and how they can be treated. By simulating various infectious disease scenarios, researchers aim to identify effective medical countermeasures and treatments. Patients may benefit from advancements in therapies that arise from these models, as they help in the development of new medications and vaccines. The approach involves rigorous testing and evaluation of potential treatments in controlled environments before they are applied in clinical settings.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and more effective treatments for infectious diseases.
How similar studies have gone: Other research has shown success in developing pre-clinical models for infectious diseases, indicating that this approach is both tested and promising.
Where this research is happening
-
Johns Hopkins University
Baltimore, United States Active
Related research
Other NIH-funded projects on the same topics.
-
Targeting hidden brain injuries in iTTP to improve long-term brain health
A researcher aims to find out how silent brain injuries in people with immune thrombotic thrombocytopenic purpura (iTTP) happen, how they affect thinking and stroke risk, and how to prevent them.
-
Accelerated flap coverage for severe leg injuries: earlier reconstruction vs standard timing
This study tests whether doing early flap coverage after a severe leg injury lowers infection risk and improves healing for patients with open wounds and bone injury.
-
Placebo-controlled shunting for iNPH: does the surgery help with walking and balance?
A doctor-led trial at Johns Hopkins will test whether a shunt surgery improves walking and balance in older adults with idiopathic normal pressure hydrocephalus.
-
Omalizumab for COPD patients with allergen sensitization and exposure
A multicenter trial will test whether adding omalizumab helps people with COPD who are allergic to common indoor allergens and are exposed to them.
-
Johns Hopkins Total Worker Health Center focusing on mental health
A nationwide center at Johns Hopkins is working to improve mental health and well-being among workers by studying workplace health strategies and translating findings into practical tools.
-
Role of fat droplets in liver fat and inflammatory signals in NAFLD
A study at Johns Hopkins will explore how fat droplets in the liver influence molecules that drive inflammation and progression of non-alcoholic fatty liver disease (NAFLD) in adults.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.